Hints and tips:
Related Topics
...Auden Mckenzie and Actavis UK increased the price of a 10mg packet by more than 10,000 per cent compared with the original branded version of the drug, the CMA said....
...Auden McKenzie hiked prices by over 10,000 per cent and paid off would-be competitors, a practice continued by Actavis UK when it took over sales of the tablets in 2015, the regulator said....
AbbVie’s planned $63bn purchase of the Botox-maker will earn $123m for bank
David Tepper’s Appaloosa hedge fund had been instigating for change
...The firm’s original investment in Allergan was a money-spinner, reaping gains of $2.3bn before the company agreed a sale to Actavis....
...Actavis to keep prices artificially high....
...The CMA also alleges that Actavis UK abused its dominant position by inducing Concordia to delay its independent entry into the market....
...The group has ongoing patent disputes with Mylan, Actavis, Par, Sandoz, Alvogen and Rhodes Pharmaceuticals, all of which are attempting to launch their own opioid addiction treatments....
...It is the second time in recent months that the CMA has said it would investigate Actavis over pricing....
...However, the CMA said that “by charging excessive and unfair pricing” Actavis had broken competition law....
...The court also gave a partial victory to drugmakers Actavis and Par Pharmaceutical, which had lost a patent battle with Indivior....
...The relevant SEC filings were made by Allergan, Inc. prior to its acquisition by Actavis plc....
...Actavis was sold last year by Allergan of the US to Israel’s Teva for $40.5bn....
...Teva, the Israeli maker of generic drugs, bought Actavis Generics from the US’s Allergan for $40.5bn....
...It is also facing an appeal in a patent battle against Actavis and Par Pharmaceutical....
...US drugmaker Pfizer plans to continue a legal battle with rival Actavis over the way its blockbuster drug Lyrica is sold in the UK after the Court of Appeal on Thursday rejected a claim of patent infringement...
...Less than a year later Forest was acquired by Actavis (which subsequently merged with Allergan) resulting in massive gains for Forest shareholders....
...In 2013 Ireland-based Warner Chilcott bought US-based Actavis, then in 2015, Actavis bought US-based Allergan....
...Allergan, previously known as Actavis, was itself one of numerous lesser-known US companies to have “redomiciled” to Ireland or other lower-tax countries....
...Analysts pinned the drop to nerves awaiting the outcome of Indivior’s patent infringement lawsuit against Actavis and Par, expected shortly....
...While generic drugmakers Actavis and Par are expected to appeal against the verdict, Indivior will now have at least another year to launch its successor treatment, a monthly injection, said Deutsche Bank...
...Alpharma’s infringement resulted in fines of £1.5m imposed on Actavis, Xellia Pharmaceuticals, and Alpharma, companies which made up the original Alpharma company....
...How did we get into this world of corporate flux, in which companies such as Valeant and Actavis, which acquired Allergan and renamed itself, gobble up others before most people have learnt their peculiar...
...Teva of Israel is close to completing its $40bn takeover of Allergan’s Actavis generics division and Mylan of the US last month agreed to buy Meda of Sweden for $7.2bn....
International Edition